Incidence and risk factors for stroke in American Indians: the Strong Heart Study

Ying Zhang, James M Galloway, Thomas K Welty, David O Wiebers, Jack P Whisnant, Richard B Devereux, Jorge R Kizer, Barbara V Howard, Linda D Cowan, Jeunliang Yeh, W James Howard, Wenyu Wang, Lyle Best, Elisa T Lee, Ying Zhang, James M Galloway, Thomas K Welty, David O Wiebers, Jack P Whisnant, Richard B Devereux, Jorge R Kizer, Barbara V Howard, Linda D Cowan, Jeunliang Yeh, W James Howard, Wenyu Wang, Lyle Best, Elisa T Lee

Abstract

Background: There are few published data on the incidence of fatal and nonfatal stroke in American Indians. The aims of this observational study were to determine the incidence of stroke and to elucidate stroke risk factors among American Indians.

Methods and results: This report is based on 4549 participants aged 45 to 74 years at enrollment in the Strong Heart Study, the largest longitudinal, population-based study of cardiovascular disease and its risk factors in a diverse group of American Indians. At baseline examination in 1989 to 1992, 42 participants (age- and sex-adjusted prevalence proportion 1132/100 000, adjusted to the age and sex distribution of the US adult population in 1990) had prevalent stroke. Through December 2004, 306 (6.8%) of 4507 participants without prior stroke suffered a first stroke at a mean age of 66.5 years. The age- and sex-adjusted incidence was 679/100 000 person-years. Nonhemorrhagic cerebral infarction occurred in 86% of participants with incident strokes; 14% had hemorrhagic stroke. The overall age-adjusted 30-day case-fatality rate from first stroke was 18%, with a 1-year case-fatality rate of 32%. Age, diastolic blood pressure, fasting glucose, hemoglobin A(1c,) smoking, albuminuria, hypertension, prehypertension, and diabetes mellitus were risk factors for incident stroke.

Conclusions: Compared with US white and black populations, American Indians have a higher incidence of stroke. The case-fatality rate for first stroke is also higher in American Indians than in the US white or black population in the same age range. Our findings suggest that blood pressure and glucose control and smoking avoidance may be important avenues for stroke prevention in this population.

Conflict of interest statement

CONFLICT OF INTEREST STATEMENT

We declare that we have no conflict of interest.

References

    1. Lee ET, Cowan LD, Welty TK, Sievers M, Howard WJ, Oopik A, Wang W, Yeh J, Devereux RB, Rhoades ER, Fabsitz RR, Go O, Howard BV The Strong Heart Study. All-cause mortality and cardiovascular disease mortality in three American Indian populations, aged 45–74 years,1984–1988. American Journal of Epidemiology. 1998;147:995–1008.
    1. Frey JL, Jahnke HK, Bulfinch EW. Differences in stroke between white, Hispanic, and Native American patients: the Barrow Neurological Institute stroke database. Stroke. 1998;29:29–33.
    1. Gillum RF. The epidemiology of stroke in Native Americans. Stroke. 1995;26:514–521.
    1. Harwell TS, Oser CS, Okon NJ, Fogle CC, Helgerson SD, Gohdes D. Defining disparities in cardiovascular disease for American Indians: trends in heart disease and stroke mortality among American Indians and whites in Montana, 1991 to 2000. Circulation. 2005;112:2263–2267.
    1. Stansbury JP, Jia H, Williams LS, Vogel WB, Duncan PW. Ethnic disparities in stroke: epidemiology, acute care, and postacute outcomes. Stroke. 2005;36:374–386.
    1. Disparities in deaths from stroke among persons aged <75 years--United States, 2002. MMWR Morb Mortal Wkly Rep. 2005;54:477–481.
    1. Casper MLDC, Coolidge JN, Williams GI, Jr, Crowell A, Galloway JM, Cobb N. Atlas of Heart and Stroke Among American Indians and Alaska Natives. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and Indian Health Service; 2005.
    1. Lee ET, Welty TK, Fabsitz R, Cowan LD, Le NA, Oopik AJ, Cucchiara AJ, Savage PJ, Howard BV The Strong Heart Study. A study of cardiovascular disease in American Indians: design and methods. American Journal of Epidemiology. 1990;132:1141–1155.
    1. Howard BV, Welty TK, Fabsitz RR, Cowan LD, Oopik AJ, Le NA, Yeh J, Savage PJ, Lee ET The Strong Heart Study. Risk factors for coronary heart disease in diabetic and nondiabetic Native Americans. Diabetes. 1992;41 Suppl 2:4–11.
    1. Cowan LD, Go OT, Howard BV, Devereux RB, Pettitt DJ, Fabsitz RR, Lee ET, Welty TK. Parity, postmenopausal estrogen use, and cardiovascular disease risk factors in American Indian women: the Strong Heart Study. Journal of Women's Health. 1997;6:441–449.
    1. Howard BV, Lee ET, Yeh JL, Go O, Fabsitz RR, Devereux RB, Welty TK The Strong Heart Study. Hypertension in adult American Indians. Hypertension. 1996;28:256–264.
    1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr, Jones DW, Materson BJ, Oparil S, Wright JT, Jr, Roccella EJ. Joint National Committee on Prevention DE, Treatment of High Blood Pressure. National Heart L, Blood I, National High Blood Pressure Education Program Coordinating C. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–1252.
    1. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine. 1998;15:539–553.
    1. Morgan CLA. Immunoassay of insulin: two antibody system: plasma insulin levels in normal, subdiabetic and diabetic rats. Diabetes. 1963;12:115–126.
    1. Yurgalevitch SM, Kriska AM, Welty TK, Go O, Robbins DC, Howard BV. Physical activity and lipids and lipoproteins in American Indians ages 45–74. Medicine & Science in Sports & Exercise. 1998;30:543–549.
    1. Kriska AM, Brach JS, Jarvis BJ, Everhart JE, Fabio A, Richardson CR, Howard BV. Physical activity and gallbladder disease determined by ultrasonography. Medicine & Science in Sports & Exercise. 2007;39:1927–1932.
    1. Howard BV, Robbins DC, Sievers ML, Lee ET, Rhoades D, Devereux RB, Cowan LD, Gray RS, Welty TK, Go OT, Howard WJ. LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The Strong Heart Study. Arteriosclerosis, Thrombosis & Vascular Biology. 2000;20:830–835.
    1. Kizer JR, Wiebers DO, Whisnant JP, Galloway JM, Welty TK, Lee ET, Best LG, Resnick HE, Roman MJ, Devereux RB. Mitral annular calcification, aortic valve sclerosis, and incident stroke in adults free of clinical cardiovascular disease: the Strong Heart Study. Stroke. 2005;36:2533–2537.
    1. Siegel SCNJ. Nonparametric Statistics for the Behavioral Sciences. Second Edition ed. McGraw-Hill, Inc; 1988.
    1. Brown RD, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke. 1996;27:373–380.
    1. Incidence and Prevalence: 2007 chart book on cardiovascular and lung diseases. Bethesda, Md: National Heart, Lung, and Blood Institute; 2007.
    1. Broderick J, Brott T, Kothari R, Miller R, Khoury J, Pancioli A, Gebel J, Mills D, Minneci L, Shukla R. The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks. Stroke. 1998;29:415–421.
    1. White H, Boden-Albala B, Wang C, Elkind MS, Rundek T, Wright CB, Sacco RL. Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation. 2005;111:1327–1331.
    1. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell CJ, Roger V, Rumsfeld J, Sorlie P, Steinberger J, Thom T, Wasserthiel-Smoller S, Hong Y. Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115:e69–e171.
    1. Cupples A DAR. Some risk factors related to the incidence of cardiovascular disease and death using pooled repeated biennial measurements: the Framingham Study. 30 year follow-up. In: Kannel WWP, Garrison R, editors. The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease. National Institutes of Health publication 87-2703 Bethesda, MD: National Heart, Lung, and Blood Institute; 1987.
    1. Mittelmark MB, Psaty BM, Rautaharju PM, Fried LP, Borhani NO, Tracy RP, Gardin JM, O'Leary DH The Cardiovascular Health Study. Prevalence of cardiovascular diseases among older adults. Am J Epidemiol. 1993;137:311–317.
    1. Whisnant JP, Wiebers DO, O'Fallon WM, Sicks JD, Frye RL. A population-based model of risk factors for ischemic stroke: Rochester, Minnesota. Neurology. 1996;47:1420–1428.
    1. Davis BR, Vogt T, Frost PH, Burlando A, Cohen J, Wilson A, Brass LM, Frishman W, Price T, Stamler J. Risk factors for stroke and type of stroke in persons with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. Stroke. 1998;29:1333–1340.
    1. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;35:765–774.
    1. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990;335:827–838.
    1. Tuomilehto J, Rastenyte D, Birkenhager WH, Thijs L, Antikainen R, Bulpitt CJ, Fletcher AE, Forette F, Goldhaber A, Palatini P, Sarti C, Fagard R. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators. N Engl J Med. 1999;340:677–684.
    1. Wolf PA, D'Agostino RB, Kannel WB, Bonita R, Belanger AJ The Framingham Study. Cigarette smoking as a risk factor for stroke. Jama. 1988;259:1025–1029.
    1. Haheim LL, Holme I, Hjermann I, Leren P. Smoking habits and risk of fatal stroke: 18 years follow up of the Oslo Study. J Epidemiol Community Health. 1996;50:621–624.
    1. Jacobs DR, Jr, Adachi H, Mulder I, Kromhout D, Menotti A, Nissinen A, Blackburn H. Cigarette smoking and mortality risk: twenty-five-year follow-up of the Seven Countries Study. Arch Intern Med. 1999;159:733–740.
    1. Janghorbani M, Hu FB, Willett WC, Li TY, Manson JE, Logroscino G, Rexrode KM. Prospective study of type 1 and type 2 diabetes and risk of stroke subtypes: the Nurses' Health Study. Diabetes Care. 2007;30:1730–1735.
    1. Lawes CM, Parag V, Bennett DA, Suh I, Lam TH, Whitlock G, Barzi F, Woodward M. Blood glucose and risk of cardiovascular disease in the Asia Pacific region. Diabetes Care. 2004;27:2836–2842.
    1. Fuller JH, Stevens LK, Wang SL. Risk factors for cardiovascular mortality and morbidity: the WHO Mutinational Study of Vascular Disease in Diabetes. Diabetologia. 2001;44 Suppl 2:S54–S64.
    1. Lehto S, Ronnemaa T, Pyorala K, Laakso M. Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes. Stroke. 1996;27:63–68.
    1. Pinto A, Tuttolomondo A, Di Raimondo D, Fernandez P, Licata G. Cerebrovascular risk factors and clinical classification of strokes. Semin Vasc Med. 2004;4:287–303.
    1. Bos MJ, Koudstaal PJ, Hofman V, Breteler MM. Decreased glomerular filtration rate is a risk factor for hemorrhagic but not for ischemic stroke: the Rotterdam Study. Stroke. 2007;38:3127–3132.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner